• Lead gene therapy vector AAV development, tech transfer and manufacturing for Wet-AMD. Design and lead Process Performance Qualification (PPQ) in Adverum.
First FDA approved gene therapy product – Luxturna manufacturing platform development in Spark Therapeutics.
• 7 years Luxturna manufacturing and management, GMP and commercial production tech transfer and tech support.
• Luxturna manufacturing validation study for BLA.
• 10 years rAAV vector manufacturing and management in The Ohio State University (OSU) and Pfizer.
• 4 years postdoctoral training using rAAV as gene therapy vector for neurological disorders at OSU and Nationwide Children’s Hospital.
• 2 years Postdoctoral training in Brain and Cognitive Science at MIT • MD and PhD degrees from China